These findings implicate LMNB1::PPP2R2B as a possible modulator of tumor biology specifically within the ETV6::RUNX1-positive acute lymphoblastic leukemia (ALL) subtype, warranting further functional studies to elucidate its mechanistic impact and potential as a therapeutic target [15]. This evidence concerns the gene RUNX1 and acute lymphoblastic leukemia.